ArticleBiomedicines2023

Allopurinol versus Febuxostat: A New Approach for the Management of Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Amani Al-Shargi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.